Lonza to double production of Covid-19 vaccine at Swiss plant
Swiss biotech firm Lonza will add three more production lines to its site in Visp, southwestern Switzerland, to manufacture an active ingredient for the Moderna vaccine, as part of a larger effort to boost the global supply of doses.
This content was published on
2 minutes
swissinfo.ch/SRF/gw
Español
es
Lonza duplicará la producción de la vacuna COVID-19 en su planta suiza
The new production lines will be added gradually to three existing lines and be fully operational by early 2022, Lonza said on Thursday. The two companies signed a ten-year contract in 2020 that enables Lonza to make a drug substance for the mRNA vaccine at its plant for the global market outside the United States.
In a separate press release, Moderna said it planned to increase the overall supply to up to three billion doses by 2022. The firm calculates there will be greater demand for its vaccine as the need for booster shots is likely to grow starting next year.
The announcement comes as Lonza struggles to recruit enough workers to join its Visp plant. Biotech specialists are currently in high demand worldwide as a result of the pandemic, Swiss public television, SRF, reported, adding that the interior ministry is now actively helping Lonza to find specialists from inside the federal administration and universities, including the federal technology institutes ETH Zurich and the EPFL in Lausanne.
Lonza has reportedly recruited temporary staff from food giant Nestlé with help from the Swiss government. Moderna has blamed projected delays in shipments of the vaccine to markets such as the UK and Canada on production bottlenecks, according to Reuters.
Should raw milk sales be banned or should consumers decide?
Swiss food regulations do not allow raw milk to be sold for direct consumption. However, a loophole allows 400 raw milk vending machines to do just that.
Is artificial intelligence an advantage or a disadvantage for workers?
What is your experience with AI at work? Have you already used it? Has it helped you work better? Or has it caused you more stress, more work or caused you to lose your job? Tell us about your experiences!
Vatican reprimands Swiss bishops for their handling of abuse allegations
This content was published on
The Vatican has reprimanded several Swiss bishops in connection with allegations of sexual abuse and their handling of it, including cover-ups.
Regional bus travel authorised between Italy and Switzerland
This content was published on
Passengers on public regional bus services between Italy and Switzerland will be able to board and alight within both countries.
Switzerland still gets poor marks on fighting corruption
This content was published on
Switzerland is still not getting good marks from the Council of Europe’s Group of States when it comes to fighting corruption.
Swiss man released after arrest in connection with Austrian bomb threats
This content was published on
A 20-year-old Swiss man was arrested under suspicion that he sent emails with bomb threats against numerous institutions in Austria.
Former top diplomats call on Switzerland to keep UNRWA funding
This content was published on
Some twenty former Swiss state secretaries, and ambassadors have called on the Swiss Senate not to stop payments to UNRWA.
Public prosecutor closes church abuse case in canton Valais
This content was published on
The Public Prosecutor's Office in the southern canton of Valais has closed the case of abuse perpetrated within the Church.
Number of women in Swiss labour market more than doubled in half century
This content was published on
According to the Swiss Federal Statistical Office, women's participation in the labor market has more than doubled in half a century.
Swiss firm Lonza to help produce anti-Covid nasal spray in the US
This content was published on
As part of its agreement with American company Altimmune, Lonza will allocate a dedicated manufacturing facility for AdCOVID nasal spray vaccine.
Switzerland mulls future European coordination on medical supplies
This content was published on
“The pandemic has shown us that we are very dependent, maybe too much so, on other markets,” Swiss President Guy Parmelin has said.
Switzerland in race for sufficient Covid immunisation
This content was published on
Health authorities have called for an extra effort from the Swiss population to keep Covid infections as low as possible in the next few months.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.